Project Number ADDF-38 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2021 View Full Project Details for Easy and early plasma pTau181 detection with LUMIPULSE G platform as indicator of Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator Vandijck, Manu Principal Investigator Vandijck, Manu Awardee Organization Fujirebio Europe NV Contact PI Country Belgium Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $1,442,198 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management